{
  "main_header": {
    "sid": 1003715,
    "name": "Trident Lifeline",
    "stock_name": "Trident Lifeline",
    "full_name": "Trident Lifeline Ltd",
    "name_url": "stocks-analysis/trident-lifeline",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "263.50",
    "chg": -2.75,
    "chgp": "-1.03%",
    "dir": -1,
    "prev_price": "266.25",
    "mcapval": "318.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 543616,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE0MKA01014",
    "curr_date": "Apr 02",
    "curr_time": "",
    "bse_nse_vol": 24000,
    "exc_status": "Active",
    "traded_date": "Apr 02, 2026",
    "traded_date_str": "2026 04 02",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/trident-lifeline-1003715-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 118,
    "sid": "1003715",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/trident-lifeline-1003715"
  },
  "announcements": [
    {
      "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
      "datetime": "01-Apr-2026",
      "details": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Hardik Desai Family Trust",
      "source": "BSE"
    },
    {
      "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
      "datetime": "01-Apr-2026",
      "details": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Rupaben Jariwala",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "31-Mar-2026",
      "details": "Pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015 we wish to inform you that the Trading Window for dealing in securities of the Company shall remain closed with effect from April 01 2026 and shall re-open 48 (Forty-Eight) hours from the conclusion of the Meeting of the Board of Directors to be held for the purpose of considering the Audited Financial Results (Standalone and Consolidated) for the quarter and Year ended March 31 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

No Recent News for the Company

View All News